News

Dillon Eustace, a leading Irish law firm, recently advised BGF Investment Management, an investor in growth companies, on its €6 million investment in Vasorum Ltd. BGF was established in 2011 and has so far invested in over 300 companies, this investment is part of the firm’s €250 million fund dedicated to growth funding in Ireland.

The investment represents major equity investment for Vasorum Ltd and a strategic addition to BGF’s portfolio. Vasorum Ltd, founded in 2007, is an Irish medical device research and development company supported by Enterprise Ireland, which develops medical devices for the interventional cardiology and radiology markets. The company operating from Dublin has more than 70,000 patient implants to date in both the EU and USA.

For this deal, Dillon Eustace acted on behalf of limited partnerships BGF Ireland 1A and BGF Investments, both managed by BGF Investment Management.

The Dillon Eustace legal team on this transaction was led by Lorcan Tiernan, Partner and Head of Corporate M&A, and supported by M&A Solicitor Owen Brayden, with UK firm Potter Clarkson providing intellectual property advice.

Commenting on the deal, Lorcan Tiernan, Partner and Head of Corporate M&A said: “We are delighted to have advised on this transaction and to have worked together with a firm with such a strong track record in developing meaningful investment partnerships with entrepreneurial Irish businesses. We wish the BGF every success with this new partnership.”

- End -